Department of Thoracic Surgery, The Second Xiangya Hospital of Central South University, Changsha, China.
qi ting jie dao she qu wei sheng fu wu zhong xin, Yixing, Jiangsu, China.
Int Immunopharmacol. 2024 Dec 5;142(Pt A):113050. doi: 10.1016/j.intimp.2024.113050. Epub 2024 Sep 3.
Sepsis represents a primary cause of acute kidney injury (AKI), yet the underlying mechanisms of septic AKI remain poorly understood. Thus, there exists an urgent need for a deeper understanding of its underlying mechanisms and the development of effective therapeutic strategies. Our study reveals a notable induction in microRNA-202-5p (miR-202-5p) levels within renal tubular cells in septic AKI both in vivo and in vitro models. Treatment of renal tubular cells with LPS induced NF-κB activation, which was linked to the induction of miR-202-5p. ChIP assays confirmed NF-κB binding to the miR-202-5p gene promoter upon LPS stimulation. Functionally, miR-202-5p mimics attenuated tubular cell death, kidney injury, and intra-renal inflammatory cytokine production, whereas inhibition of miR-202-5p conferred injurious effects in septic AKI. Notably, miR-202-5p suppressed the expression of High Mobility Group Box 2 (HMGB2) in both in vitro and in vivo septic AKI models. Luciferase microRNA target assays further validated HMGB2 as a direct target of miR-202-5p. Knockdown of HMGB2 inhibits LPS-induced NF-κB activation in septic AKI, as evidenced by HMGB2 siRNA transfection significantly inhibited the nuclear translocation of NF-κB. Together, these findings elucidate the NF-κB/miR-202-5p/HMGB2 negative feedback loop which can attenuate kidney injury by inhibiting renal inflammation in septic AKI. Our findings open new avenues for developing targeted therapies to manage septic AKI effectively.
脓毒症是急性肾损伤(AKI)的主要原因,但脓毒症 AKI 的潜在机制仍知之甚少。因此,迫切需要更深入地了解其潜在机制,并开发有效的治疗策略。我们的研究表明,在脓毒症 AKI 的体内和体外模型中,肾小管细胞中 microRNA-202-5p(miR-202-5p)水平显著升高。用 LPS 处理肾小管细胞可诱导 NF-κB 激活,这与 miR-202-5p 的诱导有关。ChIP 实验证实,LPS 刺激后 NF-κB 结合到 miR-202-5p 基因启动子上。功能上,miR-202-5p 模拟物可减轻肾小管细胞死亡、肾损伤和肾内炎性细胞因子的产生,而抑制 miR-202-5p 则可加重脓毒症 AKI 的损伤作用。值得注意的是,miR-202-5p 在体外和体内脓毒症 AKI 模型中均可抑制高迁移率族蛋白 B2(HMGB2)的表达。荧光素酶 miRNA 靶标测定进一步验证了 HMGB2 是 miR-202-5p 的直接靶标。在脓毒症 AKI 中,敲低 HMGB2 可抑制 LPS 诱导的 NF-κB 激活,HMGB2 siRNA 转染显著抑制了 NF-κB 的核转位。总之,这些发现阐明了 NF-κB/miR-202-5p/HMGB2 负反馈环可通过抑制脓毒症 AKI 中的肾炎症来减轻肾损伤。我们的研究结果为开发有效的靶向治疗脓毒症 AKI 提供了新的途径。